Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$14,804,926
+$420,122 QoQ
Shares Held
58,294
-0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.03%
of 13F equity value
Holder Rank
#892
of 4,676 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Farmers National Bank holds $29,011,578 across 8 Drug Manufacturers - General names. JNJ ranks #1 (51.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
58,294 | $14,804,926 | |
| 2 | LLY |
ELI LILLY & Co
|
4,087 | $4,902,070 | |
| 3 | ABBV |
AbbVie Inc.
|
13,102 | $3,296,987 | |
| 4 | PFE |
Pfizer Inc
|
83,320 | $2,006,345 | |
| 5 | AMGN |
Amgen Inc
|
5,193 | $1,880,488 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,329 | $1,198,776 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,167 | $585,822 | |
| 8 | NVS |
Novartis AG
|
2,145 | $336,164 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,804,926 | 58,294 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $14,384,804 | 58,848 | Shares | Sole | 2026-06-08 | |
| 2025-12-31 | $12,562,071 | 60,701 | Shares | Defined | 2026-03-12 | |
| 2025-09-30 | $10,761,775 | 58,040 | Shares | Defined | 2025-12-15 | |
| 2025-06-30 | $9,011,332 | 58,994 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,842,603 | 59,350 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,413,557 | 58,177 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $8,795,908 | 60,180 | Shares | Defined | 2024-08-28 | |
| 2024-03-31 | $9,595,013 | 60,655 | Shares | Defined | 2024-08-28 | |
| 2023-12-31 | $9,292,487 | 59,286 | Shares | Defined | 2024-08-28 | |
| 2023-09-30 | $9,184,732 | 58,971 | Shares | Defined | 2024-08-28 | |
| 2023-06-30 | $9,514,254 | 57,481 | Shares | Defined | 2024-08-28 | |
| 2023-03-31 | $8,742,000 | 56,400 | Shares | Defined | 2024-08-28 | |
| 2022-12-31 | $9,895,932 | 56,020 | Shares | Defined | 2024-08-28 | |
| 2022-09-30 | $9,209,582 | 56,376 | Shares | Defined | 2024-08-28 | |
| 2022-06-30 | $9,974,109 | 56,189 | Shares | Defined | 2024-08-28 | |
| 2022-03-31 | $10,015,975 | 56,514 | Shares | Defined | 2024-08-28 | |
| 2021-12-31 | $9,728,750 | 56,870 | Shares | Defined | 2024-08-28 | |
| 2021-09-30 | $10,249,436 | 63,464 | Shares | Defined | 2024-08-28 | |
| 2021-06-30 | $10,679,270 | 64,825 | Shares | Defined | 2024-08-28 | |
| 2021-03-31 | $10,097,663 | 61,440 | Shares | Defined | 2024-08-28 | |
| 2020-12-31 | $9,987,963 | 63,464 | Shares | Defined | 2024-08-28 | |
| No filing history on record for this holder in this stock. | ||||||